2 | Good | NO2 | None | None |
38 | Good | O3 PPB | None | None |
132 | Unhealthy for Sensitive Groups | PMSC | Increasing likelihood of respiratory symptoms in sensitive individuals, aggravation of heart or lung disease and premature mortality in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
2 | Good | NO2 | None | None |
37 | Good | O3 PPB | None | None |
130 | Unhealthy for Sensitive Groups | PMSC | Increasing likelihood of respiratory symptoms in sensitive individuals, aggravation of heart or lung disease and premature mortality in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
2 | Good | NO2 | None | None |
129 | Unhealthy for Sensitive Groups | PMSC | Increasing likelihood of respiratory symptoms in sensitive individuals, aggravation of heart or lung disease and premature mortality in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
126 | Unhealthy for Sensitive Groups | PMSC | Increasing likelihood of respiratory symptoms in sensitive individuals, aggravation of heart or lung disease and premature mortality in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
2 | Good | NO2 | None | None |
123 | Unhealthy for Sensitive Groups | PMSC | Increasing likelihood of respiratory symptoms in sensitive individuals, aggravation of heart or lung disease and premature mortality in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
2 | Good | NO2 | None | None |
122 | Unhealthy for Sensitive Groups | PMSC | Increasing likelihood of respiratory symptoms in sensitive individuals, aggravation of heart or lung disease and premature mortality in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |